New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 11, 2014
10:09 EDTMNKDMannKind rallies after global licensing agreement for Afrezza
The company and Sanofi (SNY) entered into a worldwide exclusive agreement to develop and commercialize Afrezza Inhalation Powder. The stock is up over 15.5% at time of writing to $9.40, off earlier highs. At that price, next resistance is at $9.63. Support is at $9.29.
News For MNKD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 19, 2015
16:01 EDTMNKDOptions Update; May 19, 2015
iPath S&P 500 VIX Short-Term Futures down 27c to 19.17. Option volume leaders: AAPL BAC WMT MSFT FB TWTR MNKD NFLX T PBR
May 18, 2015
05:50 EDTMNKDStocks with implied volatility movement; BBRY MNKD
Stocks with implied volatility movement; BlackBerry (BBRY) 55, MannKind (MNKD) 75 according to iVolatility.
May 15, 2015
08:23 EDTMNKDJefferies sees 'good interest' in MannKind's Afrezza
Subscribe for More Information
May 12, 2015
05:58 EDTMNKDStocks with implied volatility movement; MNKD BBRY
Subscribe for More Information
May 11, 2015
12:51 EDTMNKDOn The Fly: Top stock stories at midday
Subscribe for More Information
09:59 EDTMNKDOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:21 EDTMNKDOn The Fly: Pre-market Movers
Subscribe for More Information
06:43 EDTMNKDMannKind downgraded to Underweight from Neutral at JPMorgan
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use